ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Basic Science Center Funding Plan Clarified; Janice Feldman Leaves As Chief Of NIH Nursing

February 17, 1989

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

NCI-Approved Trials Listed

March 30, 2007

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014